Kallyope
PrivateLast Round
Grant
May 10, 2023
Est. Valuation
$1.14B
Total Funding Raised
$487.2M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Kallyope is a biotechnology company that integrates advanced technologies to understand gut-brain biology for the development of novel therapeutics targeting neurological and metabolic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Kallyope Comparables
Compare Kallyope with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Axial Therapeutics | 79% | |
| Structure Therapeutics | 79% | |
| Axial Therapeutics | 78% | |
Kallyope Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 10, 2023 | ||||
| Series D | Feb 15, 2022 | ||||
| Series C | Mar 25, 2020 | ||||
| Series B | Dec 5, 2018 | ||||
| Series A | Dec 10, 2015 |
Key People
Founding team and executive leadership
Kallyope Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| The Column Group | Series B, Series C, Series A, Series D |
| Parkwood | Series D |
| StepStone Group | Series D, Series C |
| Lux Capital | Series D, Series B, Series C, Series A |
| The Chernin Group | Series A, Series B, Series C, Series D |
| Two Sigma Ventures | Series D, Series B, Series C |
| Bill & Melinda Gates Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 23, 2026
Monthly visitors increased 51% MoM.
- Mar 5, 2026
Presented Phase 2b migraine study results at the AAN Annual Meeting.
Kallyope Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Kallyope's valuation, stock price, and market status.